These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36561245)

  • 21. Economic Burden of Epidermolysis Bullosa Disease in Iran.
    Forghani SF; Jahangiri R; Ghasemi F; Shirani R; Bagheri H; Mahmoodi R; Bagheri Faradonbeh S
    Med J Islam Repub Iran; 2021; 35():146. PubMed ID: 35321378
    [No Abstract]   [Full Text] [Related]  

  • 22. Economic burden associated with acute myeloid leukemia treatment.
    Zeidan AM; Mahmoud D; Kucmin-Bemelmans IT; Alleman CJ; Hensen M; Skikne B; Smith BD
    Expert Rev Hematol; 2016 Jan; 9(1):79-89. PubMed ID: 26568358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic Burden of Colorectal Cancer: A Case of Fars, Iran.
    Jafari A; Alamdarloo PM; Dehghani M; Bastani P; Ravangard R
    Cancer Control; 2021; 28():10732748211009952. PubMed ID: 33882706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology, management, and economic impact of acute myeloid leukemia and myelodysplastic syndrome in Spain at the hospital level: a claims database analysis.
    Marsà A; Ascanio M; Diaz-García J; Darbà J
    J Med Econ; 2020 Dec; 23(12):1477-1484. PubMed ID: 33084440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expert panel on practice patterns in the management of cow's milk protein allergy and associated economic burden of disease on health service in Turkey.
    Sekerel BE; Seyhun O
    J Med Econ; 2017 Sep; 20(9):923-930. PubMed ID: 28602101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of the prevalence and direct medical costs of chronic myeloid leukemia in the I.R. of Iran in the era of tyrosine kinase inhibitors.
    Daroudi R; Mirzania M; Nikravanfard N; Sadighi S; Sedighi Z; Zendehdel K
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e416-e422. PubMed ID: 26990676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic burden of multiple sclerosis: a cross-sectional study in Iran.
    Rezaee M; Keshavarz K; Izadi S; Jafari A; Ravangard R
    Health Econ Rev; 2022 Jan; 12(1):2. PubMed ID: 34981265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic burden of psoriasis in Southern Iran in 2022.
    Ravangard R; Mirzaei M; Ghahartars M; Jafari A
    Arch Public Health; 2024 Jul; 82(1):104. PubMed ID: 38978131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic Burden of Smoking in Iran: A Prevalence-Based Annual Cost Approach.
    Rezaei S; Karami Matin B; Hajizadeh M; Bazyar M; Akbari Sari A
    Asian Pac J Cancer Prev; 2017 Oct; 18(10):2867-2873. PubMed ID: 29072438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The economic burden of osteoporosis in Iran in 2020.
    Ostovar A; Mousavi A; Sajjadi-Jazi SM; Rajabi M; Larijani B; Fahimfar N; Daroudi R
    Osteoporos Int; 2022 Nov; 33(11):2337-2346. PubMed ID: 35821307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current and future economic burden of diabetes among working-age adults in Asia: conservative estimates for Singapore from 2010-2050.
    Png ME; Yoong J; Phan TP; Wee HL
    BMC Public Health; 2016 Feb; 16():153. PubMed ID: 26880337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.
    Cruess AF; Zlateva G; Xu X; Soubrane G; Pauleikhoff D; Lotery A; Mones J; Buggage R; Schaefer C; Knight T; Goss TF
    Pharmacoeconomics; 2008; 26(1):57-73. PubMed ID: 18088159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The economic burden of bipolar disorder: a case study in Southern Iran.
    Shaker Z; Goudarzi Z; Ravangard R; Shaker Z; Hedayati A; Keshavarz K
    Cost Eff Resour Alloc; 2024 Jul; 22(1):55. PubMed ID: 39026286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The economic burden of prostate cancer - a Swedish prevalence-based register study.
    Hao S; Östensson E; Eklund M; Grönberg H; Nordström T; Heintz E; Clements M
    BMC Health Serv Res; 2020 May; 20(1):448. PubMed ID: 32434566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Healthcare expenses for treatment of acute myeloid leukemia.
    Bewersdorf JP; Shallis RM; Wang R; Huntington SF; Perreault S; Ma X; Zeidan AM
    Expert Rev Hematol; 2019 Aug; 12(8):641-650. PubMed ID: 31159602
    [No Abstract]   [Full Text] [Related]  

  • 36. The economic burden of road traffic injuries until one-year after hospitalization: A survey study.
    Zakeri R; Nosratnejad S; Sadeghi-Bazargani H; Dalal K; Yousefi M
    Accid Anal Prev; 2021 Dec; 163():106459. PubMed ID: 34710782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic reviews of economic burden and health-related quality of life in patients with acute myeloid leukemia.
    Bosshard R; O'Reilly K; Ralston S; Chadda S; Cork D
    Cancer Treat Rev; 2018 Sep; 69():224-232. PubMed ID: 30098484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Productivity losses and public finance burden attributable to breast cancer in Poland, 2010-2014.
    Łyszczarz B; Nojszewska E
    BMC Cancer; 2017 Oct; 17(1):676. PubMed ID: 29017454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disparities in economic burden for children with leukemia insured by resident basic medical insurance: evidence from real-world data 2015-2019 in Guangdong, China.
    Zhan C; Wu Z; Yang L; Yu L; Deng J; Luk K; Duan C; Zhang L
    BMC Health Serv Res; 2022 Feb; 22(1):229. PubMed ID: 35183172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic burden attributable to functional bowel disorders in Iran: a cross-sectional population-based study.
    Moghimi-Dehkordi B; Vahedi M; Pourhoseingholi MA; Khoshkrood Mansoori B; Safaee A; Habibi M; Pourhoseingholi A; Zali MR
    J Dig Dis; 2011 Oct; 12(5):384-92. PubMed ID: 21955432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.